Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 14902 [2017-05734]

Download as PDF 14902 Federal Register / Vol. 82, No. 55 / Thursday, March 23, 2017 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces a meeting for the initial review of applications in response to Funding Opportunity Announcement, RFA–CE–17–002, Development and Evaluation of Sports Concussion Prevention Strategies. Times and Dates: In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces a meeting for the initial review of applications in response to Funding Opportunity Announcement (FOA) DD17–001, Coordinating Center for Research to Promote the Health of Children with Birth Defects and People with Developmental and Other Disabilities. Time and Date: 11:00 a.m.–6:00 p.m., EDT, April 19, 2017 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Coordinating Center for Research to Promote the Health of Children with Birth Defects and People with Developmental and Other Disabilities’’, FOA DD17–001. Contact Person for More Information: Jaya Raman Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway, Mailstop F80, Atlanta, Georgia 30341, Telephone: (770) 488–6511, kva5@ cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. sradovich on DSK3GMQ082PROD with NOTICES 8:00 a.m.–5:00 p.m., EDT, April 19, 2017 (Closed) 8:00 a.m.–5:00 p.m., EDT, April 20, 2017 (Closed) Place: Crowne Plaza Atlanta Perimeter at Ravinia, 4355 Ashford Dunwoody Road, Atlanta, GA 30346. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Development and Evaluation of Sports Concussion Prevention Strategies’’, RFA–CE–17–002. Contact Person for More Information: Oscar Tarrago, M.D., M.P.H., Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F63, Atlanta, Georgia 30341–3724, Telephone: (770) 488–3492. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Claudette Grant, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2017–05732 Filed 3–22–17; 8:45 am] Claudette Grant, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. 17:13 Mar 22, 2017 6:30 p.m.–8:00 p.m., EDT, April 19, 2017 (Closed) 8:00 a.m.–6:00 p.m., EDT, April 20, 2017 (Closed) 8:00 a.m.–6:00 p.m., EDT, April 21, 2017 (Closed) Place: AC Hotel Atlanta Buckhead at Phipps Plaza, 3600 Wieuca Rd. NE., Atlanta, GA 30326 Telephone: (470) 231–3030. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Centers for Agricultural Safety and Health’’, PAR15–353. Contact Person for More Information: Michael Goldcamp, Ph.D., Scientific Review Officer, CDC, 1095 Willowdale Road, Morg Bldg. H, Room 1806, Mailstop 1808, Morgantown, WV Telephone: (304) 285–5951, EHG8@ CDC.GOV. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. [FR Doc. 2017–05734 Filed 3–22–17; 8:45 am] Claudette Grant, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. BILLING CODE 4163–18–P [FR Doc. 2017–05735 Filed 3–22–17; 8:45 am] BILLING CODE 4163–18–P VerDate Sep<11>2014 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces a meeting for the initial review of application in response to Funding Opportunity Announcement (FOA) PAR15–353, Centers for Agricultural Safety and Health. Times and Dates: BILLING CODE 4163–18–P Jkt 241001 PO 00000 Frm 00038 Fmt 4703 Sfmt 9990 E:\FR\FM\23MRN1.SGM 23MRN1

Agencies

[Federal Register Volume 82, Number 55 (Thursday, March 23, 2017)]
[Notices]
[Page 14902]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-05734]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces a meeting for the initial review of 
applications in response to Funding Opportunity Announcement (FOA) 
DD17-001, Coordinating Center for Research to Promote the Health of 
Children with Birth Defects and People with Developmental and Other 
Disabilities.
    Time and Date: 11:00 a.m.-6:00 p.m., EDT, April 19, 2017 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and 
the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters for Discussion: The meeting will include the initial 
review, discussion, and evaluation of applications received in response 
to ``Coordinating Center for Research to Promote the Health of Children 
with Birth Defects and People with Developmental and Other 
Disabilities'', FOA DD17-001.
    Contact Person for More Information: Jaya Raman Ph.D., Scientific 
Review Officer, CDC, 4770 Buford Highway, Mailstop F80, Atlanta, 
Georgia 30341, Telephone: (770) 488-6511, kva5@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2017-05734 Filed 3-22-17; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.